August 2026

MotorCycle Holdings Limited (ASX:MTO) posted a 21.3% revenue increase and 34% net profit growth for FY26, driven by organic sales and acquisitions. The company declared a higher final dividend and released its inaugural climate-related financial disclosures.

Nimy Resources has reported metallurgical tests confirming strong extraction rates of gallium and rare earth elements from its Block 3 resource at the Mons Project, underpinning its proprietary processing flowsheet and advancing its scoping study.

Future Generation Global's half-year profit fell sharply as its portfolio lagged global benchmarks, yet it boosted its fully franked interim dividend reflecting confidence in its income sustainability.

Calix Limited posted a 16% revenue increase to $39.2 million in FY26 driven by strong growth in its Magnesia business, while reporting a substantial net loss of $51 million largely due to a one-off impairment. The company advanced key industrial decarbonisation projects and strengthened strategic partnerships, focusing on capital-light commercialisation.

Taiton Resources has secured a farm-in agreement over EL 6468, significantly enlarging its Challenger West gold-copper project in South Australia. Historic drilling highlights shallow, high-grade mineralisation, while new soil sampling aims to sharpen upcoming drill targets.

The Koala Company posted a $24.6 million profit for FY26 on $332.3 million revenue, surpassing IPO forecasts with strong international growth and margin gains.

Mastermyne Group Limited (ASX:MYE) delivered a robust FY26 with revenue up 13% to $237.7 million and underlying profit before tax surging 148% to $15.7 million, supported by contract wins and a record order book.

COG Financial Services lifted revenue 10% to $403.4 million and net profit after tax attributable to members by 29% to $24.24 million for FY26, driven by a 51% jump in its Salary Packaging segment including the Easifleet acquisition. The company declared a fully franked 7.0 cents per share dividend, suspending its dividend reinvestment plan.

FAR Limited swung to a US$1.44 million profit for H1 2026, driven by contingent payments from its Senegal asset sale, and completed a substantial A$32.3 million capital return to shareholders.

Radiopharm Theranostics has dosed the first patient in the second cohort of its Phase 1/2a trial for RV-01, a radiopharmaceutical targeting B7-H3 expressing solid tumors, marking a key dose escalation milestone.

Green & Gold Minerals (ASX:GG1) has revealed significant copper, silver, and tin mineralisation at its Elizabeth Bluffs prospect within the Herberton Conductor Metals Project, supported by historic data and recent sampling. A 3,000m drill campaign at Mt Wandoo is set to commence in September 2026, aiming to extend high-grade gold-silver zones.

BCAL Diagnostics has increased its shareholding in Genetic Signatures to nearly a fifth, aiming to leverage infectious disease technology to complement its cancer detection portfolio.

Prescient Therapeutics (ASX:PTX) has opened a $7 million Share Purchase Plan at a significant discount to advance its lead cancer therapy PTX-100 beyond a pivotal Dose Optimisation Committee review in late 2026.

Hiremii Limited posted an 8.6% revenue increase to $32.4 million and halved its net loss in FY26, reaching adjusted EBITDA breakeven as it prepares to rebrand as AQYR Limited.

Biome Australia has delivered a standout FY26 with sales up 30% to $23.9 million and net profit after tax soaring to $3.6 million, bolstered by a non-cash deferred tax asset. The company strengthened its balance sheet while expanding manufacturing and international distribution.

WiseTech Global posted a record $1.4 billion in revenue for FY26, driven by the e2open acquisition and AI-led efficiencies, while underlying net profit rose 29%. The company outlines a confident FY27 growth outlook amid ongoing integration and innovation.

Epiminder Limited reported a $42.7 million loss for FY26, driven by clinical trial and product development costs following a $125 million IPO. The company progresses its FDA-approved Minder implantable EEG monitor with a pivotal US trial and next-gen device on track for 2028 launch.

Gateway Mining has stretched its Cowza gold mineralisation to 4.5 kilometres, unveiling continuous high-grade zones and reinforcing the Yandal Project’s emerging gold camp potential. Celia South also shines with a standout 9.7g/t intercept, as RC drilling ramps up to test mineralisation depth.

Tabcorp Holdings posted modest revenue growth and a sharp rise in net profit for FY26, while unveiling a major acquisition to accelerate its wagering technology transformation.

Lovisa Holdings reported a robust FY26 with revenue up 17.6% to A$938.8 million, expanded its global store network to 1,136 locations, and declared a 33 cent final dividend, reflecting strong momentum in key markets.

FleetPartners has received a fresh non-binding offer from a Sumitomo-led consortium valuing the company at $3.85 per share, joining a competitive field of bidders vying for control.

QEM Limited’s review of the Big It Tungsten Project in Idaho reveals significant untapped high-grade tungsten, antimony, and gold mineralisation with extensive underground workings, setting the stage for a modern exploration campaign amid strategic supply concerns.

FOS Capital reported a 12% revenue decline and an EBITDA loss of $0.5 million in FY26, impacted by softer market conditions and project delays. However, a $10 million order book and record $130 million pipeline set the stage for a potential turnaround in FY27.

Brazilian Rare Earths (ASX: BRE) has delivered a substantial expansion of its Monte Alto rare earths deposit with approximately 10,000 meters of new drilling revealing ultra-high-grade mineralisation beyond the existing resource boundaries and opening a northern growth corridor.